Top

Published in:

Open Access 01-04-2012 | Research

Correlation between high blood IL-6 level, hyperglycemia, and glucose control in septic patients

Authors: Masataka Nakamura, Shigeto Oda, Tomohito Sadahiro, Eizo Watanabe, Ryuzo Abe, Taka-aki Nakada, Yasumasa Morita, Hiroyuki Hirasawa

Published in: Critical Care | Issue 2/2012

Abstract

Introduction

The aim of the present study was to investigate the relationship between the blood IL-6 level, the blood glucose level, and glucose control in septic patients.

Methods

This retrospective observational study in a general ICU of a university hospital included a total of 153 patients with sepsis, severe sepsis, or septic shock who were admitted to the ICU between 2005 and 2010, stayed in the ICU for 7 days or longer, and did not receive steroid therapy prior to or after ICU admission. The severity of stress hyperglycemia, status of glucose control, and correlation between those two factors in these patients were investigated using the blood IL-6 level as an index of hypercytokinemia.

Results

A significant positive correlation between blood IL-6 level and blood glucose level on ICU admission was observed in the overall study population (n = 153; r = 0.24, P = 0.01), and was stronger in the nondiabetic subgroup (n = 112; r = 0.42, P < 0.01). The rate of successful glucose control (blood glucose level < 150 mg/dl maintained for 6 days or longer) decreased with increase in blood IL-6 level on ICU admission (P < 0.01). The blood IL-6 level after ICU admission remained significantly higher and the 60-day survival rate was significantly lower in the failed glucose control group than in the successful glucose control group (P < 0.01 and P < 0.01, respectively).

Conclusions

High blood IL-6 level was correlated with hyperglycemia and with difficulties in glucose control in septic patients. These results suggest the possibility that hypercytokinemia might be involved in the development of hyperglycemia in sepsis, and thereby might affect the success of glucose control.

Available only for authorised users

Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355: 773-778. 10.1016/S0140-6736(99)08415-9CrossRefPubMed

Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32: 2426-2432. 10.1161/hs1001.096194CrossRefPubMed

Rovlias A, Kotsou S: The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000, 46: 335-342. 10.1097/00006123-200002000-00015CrossRefPubMed

Marik PE: Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 2004, 30: 748-756. 10.1007/s00134-004-2167-yCrossRefPubMed

Van Cromphaut SJ, Vanhorebeek I, Van den Berghe G: Glucose metabolism and insulin resistance in sepsis. Curr Pharm Des 2008, 14: 1887-1899. 10.2174/138161208784980563CrossRefPubMed

Losser MR, Damoisel C, Payen D: Bench-to-bedside review: Glucose and stress conditions in the intensive care unit. Crit Care 2010, 14: 231. 10.1186/cc9100PubMedCentralCrossRefPubMed

Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004, 30: 536-555. 10.1007/s00134-004-2210-zCrossRefPubMed

Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34: 17-60. 10.1007/s00134-007-0934-2PubMedCentralCrossRefPubMed

Implement the Management Bundle within First 24 Hours of Care[http://www.survivingsepsis.org/Bundles/Pages/SepsisManagementBundle.aspx]

10.

Gustot T: Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care 2011, 17: 153-159. 10.1097/MCC.0b013e328344b446CrossRefPubMed

11.

Abraham E, Mervyn S: Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 2007, 35: 2408-2416. 10.1097/01.CCM.0000282072.56245.91CrossRefPubMed

12.

Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M: Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine 2005, 29: 169-175. 10.1016/j.cyto.2004.10.010CrossRefPubMed

13.

Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y, Shinozaki K, Hirasawa H: Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care 2010, 14: R27. 10.1186/cc8898PubMedCentralCrossRefPubMed

14.

Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC, GenIMS Investigators: Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007, 167: 1655-1663. 10.1001/archinte.167.15.1655PubMedCentralCrossRefPubMed

15.

Tschaikowsky K, Hedwig-Geissing M, Braun GG, Radespiel-Troeger M: Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. J Crit Care 2011, 26: 54-64. 10.1016/j.jcrc.2010.04.011CrossRefPubMed

16.

Gregoric P, Sijacki A, Stankovic S, Radenkovic D, Ivancevic N, Karamarkovic A, Popovic N, Karadzic B, Stijak L, Stefanovic B, Milosevic Z, Bajec D: SIRS score on admission and initial concentration of IL-6 as severe acute pancreatitis outcome predictors. Hepatogastroenterology 2010, 57: 349-353.PubMed

17.

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20: 864-874. 10.1097/00003246-199206000-00025CrossRef

18.

Grimble RF: Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 2002, 5: 551-559. 10.1097/00075197-200209000-00015CrossRefPubMed

19.

Petit F, Bagby GJ, Lang CH: Tumor necrosis factor mediates zymosan-induced increase in glucose flux and insulin resistance. Am J Physiol 1995, 268: E219-E228.PubMed

20.

Rotter V, Nagaev I, Smith U: Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003, 278: 45777-45784. 10.1074/jbc.M301977200CrossRefPubMed

21.

Müller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B, Giani G, Illig T, Thorand B, Kolb H: Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 2002, 45: 805-812. 10.1007/s00125-002-0829-2CrossRefPubMed

22.

Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K, Yano Y: Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998, 83: 859-862. 10.1210/jc.83.3.859PubMed

23.

Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet): Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358: 125-139. 10.1056/NEJMoa070716CrossRefPubMed

24.

NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360: 1283-1297.CrossRef

25.

Eslami S, Abu-Hanna A, de Keizer NF, Bosman RJ, Spronk PE, de Jonge E, Schultz MJ: Implementing glucose control in intensive care: a multicenter trial using statistical process control. Intensive Care Med 2010, 36: 1556-1565. 10.1007/s00134-010-1924-3PubMedCentralCrossRefPubMed

26.

Meyfroidt G, Wouters P, De Becker W, Cottem D, Van den Berghe G: Impact of a computer-generated alert system on the quality of tight glycemic control. Intensive Care Med 2011, 37: 1151-1157. 10.1007/s00134-011-2159-7CrossRefPubMed

27.

Hanazaki K, Maeda H, Okabayashi T: Tight perioperative glycemic control using an artificial endocrine pancreas. Surg Today 2010, 40: 1-7. 10.1007/s00595-009-4061-2CrossRefPubMed

28.

Rimmelé T, Kellum JA: Clinical review: Blood purification for sepsis. Crit Care 2011, 15: 205.PubMedCentralCrossRefPubMed

29.

Nakamura M, Oda S, Sadahiro T, Hirayama Y, Watanabe E, Tateishi Y, Nakada TA, Hirasawa H: Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator. Contrib Nephrol 2010, 166: 73-82.CrossRefPubMed

Title: Correlation between high blood IL-6 level, hyperglycemia, and glucose control in septic patients
Authors: Masataka Nakamura
Shigeto Oda
Tomohito Sadahiro
Eizo Watanabe
Ryuzo Abe
Taka-aki Nakada
Yasumasa Morita
Hiroyuki Hirasawa
Publication date: 01-04-2012
Publisher: BioMed Central
Published in: Critical Care / Issue 2/2012
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc11301

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Correlation between high blood IL-6 level, hyperglycemia, and glucose control in septic patients

Abstract

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2012

Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis

Is there still a place for vasopressors in the treatment of cardiac arrest?

Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype?

Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial

Negative- versus positive-pressure ventilation in intubated patients with acute respiratory distress syndrome

Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study